Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Korean Medical Science ; : 768-772, 2006.
Artículo en Inglés | WPRIM | ID: wpr-211991

RESUMEN

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome associated with anticonvulsant drugs is a rare but potentially life-threatening disease that occurs in response to arene oxide producing anticonvulsant such as phenytoin and carbamazepine. There have been many reports of cross reactivity among the anticonvulsants upon first exposure to the offending drugs. However, there has been few data describing the development of DRESS syndrome after switching medication from previously well-tolerated phenytoin to carbamazepine, and the induction of hypersensitivity to phenytoin by DRESS to carbamazepine. We experienced a case of a 40-yr-old man who had uncontrolled seizure that led to the change of medication from the long-term used phenytoin to carbamazepine. He developed DRESS syndrome after changing the drugs. We stopped carbamazepine and restored phenytoin for seizure control, but his clinical manifestations progressively worsened and he recovered only when both drugs were discontinued. Patch tests with several anticonvulsants showed positive reactions to both carbamazepine and phenytoin. Our case suggests that hypersensitivity to a previously tolerated anticonvulsant can be induced by DRESS to another anticonvulsant, and that the patch test may be a useful method for detecting cross-reactive drugs in anticonvulsant-associated DRESS syndrome.


Asunto(s)
Masculino , Humanos , Adulto , Síndrome , Piel/efectos de los fármacos , Fenitoína/inmunología , Hipersensibilidad a las Drogas/inmunología , Erupciones por Medicamentos/etiología , Carbamazepina/efectos adversos , Anticonvulsivantes/efectos adversos
2.
Arch. argent. dermatol ; 44(2): 61-5, mar.-abr. 1994. ilus
Artículo en Español | LILACS | ID: lil-136630

RESUMEN

Dos semanas después de iniciar una terapéutica con difenilhidantoína, un paciente presenta un cuadro compatible con el Síndrome de Hipersensibilidad a los Anticonvulsivantes. Por el carácter potencialmente mortal de la entidad, se describen sus características, con el propósito de facilitar su diagnóstico precoz, poniendo especial énfasis en la adecuada selección de un anticonvulsivante sustituto, dado que pueden existir reacciones cruzadas en un alto porcentaje de los casos


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Anticonvulsivantes/efectos adversos , Hipersensibilidad a las Drogas/etiología , Fenitoína/efectos adversos , Síndrome de Stevens-Johnson/etiología , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/fisiopatología , Fenitoína/administración & dosificación , Fenitoína/inmunología , Síndrome de Stevens-Johnson/inmunología , Síndrome de Stevens-Johnson/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA